Latina patients with breast cancer given more information more likely to enter clinical trials
the ONA take:
According to new findings presented at the American Association of Cancer Research conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved in San Antonio, Texas, Latina patients with breast cancer given information about clinical trials in various way had much more awareness of clinical trials versus women who received the typical information.
One particular method was culturally sensitive, computer-based videos that provided information on breast cancer clinical trials.
For the study, investigators enrolled 71 Latina patients with breast cancer who were eligible to take part in clinical trial at the Cancer Therapy and Research Center in San Antonio. Researchers are still recruiting women for the study. Participants randomly assigned to receive additional information watched culturally-sensitive, computer-based videos, read a booklet, and had assistance from a patient navigator.
Women with additional information were more of aware of how to participate in a clinical trial and the risks and benefits. Women in the process of participating in a breast cancer clinical trial rose from 38 to 75% after being provided the additional information about clinical trials. The researchers hope to expand the study to include patients with all types of cancer.
Latina patients with breast cancer had much more awareness of clinical trials.
Latina breast cancer patients provided with information about clinical trials in multiple ways, including a culturally sensitive, computer-based video on breast cancer clinical trials, had much greater awareness of clinical trials compared with patients who received usual-care information, according to data presented at the American Association for Cancer Research (AACR) conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Nov. 9–12.
After receiving the additional information, the proportion of Latina breast cancer patients taking steps toward participating in a clinical trial increased from 38 percent to 75 percent.
Sign Up for Free e-newsletters
- Leukemia Risk in Children, Maternal Use of Hormonal Contraception Linked in Population Study
- Molecular Features May Predict Response in Primary Pancreatic Cancer
- Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care
- Commission Seeks Standardized Adverse Event Assessments in Hematologic Malignancies
- Chemoimmunotherapy prolongs PFS in metastatic triple-negative breast cancer
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Counseling Patients on Oral Chemotherapy
- Patients and Caregivers Worry About Cost of Cancer Care
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Head and Neck Cancer Survivors Have Increased Suicide Risk
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|